Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Conspiracy theories ...
as American as apple pie ...
How about someone de risked 1.5m shares .. because that's all it was
OK try this, call your broker / bank ask them how many you can short right now ... it will be zero
Ah ok sure , JD can you just give me the befit of your knowledge and explain how that works?
Yes and the highest I`ve seen since my first post about it a few weeks back was about 300k which is negligible.
ONCE AGAIN ZERO SHARES AVAILABLE TO BORROW (TO SHORT)
Pfizer, BioNTech Covid Vaccine Meets Expectations: FDA Staff
By Cristin Flanagan
(Bloomberg) -- Pfizer Inc. and partner BioNTech SE’s Covid-19 vaccine meets expectations on agency guidance and is enough to spur an agency review, according to staff of the U.S. Food and Drug Administration. The experimental vaccine, BNT162b2, is on track to be the first shot to get an emergency authorization in the U.S.
Study sponsors “provided adequate information to ensure the vaccine’s quality and consistency for authorization of the product under an EUA” agency reviewers said in briefing documents ahead of a Thursday panel
After the meeting, some Wall Street analysts have said an authorization is possible within days; Pfizer’s shot received an emergency nod in the U.K. on Dec. 2
The Dec. 10 panel is not expected to be contentious, Barclays analyst Carter Gould told Bloomberg News he was expecting “smooth sailing” for Pfizer’s shot, though options data indicate shares could be volatile
NOTE: Moderna’s shot, which uses a similar messenger-RNA technology, will face an FDA advisory committee on Dec. 17
PFE shares little change, BNTX shares down 1%
+44 the code for the UK ?
UK approval ?? are you sure ??
Link please .. in fact forget the link I believe you ..
Yea go NWBO ...
No regulator will give a toss if a 10q is late with whats been going on specifically in America , LA in lock down etc etc
Idunno , never ever talk someone in to buy or out of selling ..
Senti , so what do you think would have happened to the price on 14th December if there hadn't been a rukus yesterday and a tacit admission of the extension by Innes ? ... and in any case my opinion is whoever sold yesterday probably about 1.5m shares had already made their mind up to sell by virtue of the fact if you've got that level of investment you'd understand a definitive short dated warrant extension is positive not negative vs the undefintive end date situation we were in.
Also Marzan posted the warrant extensions discussions weeks ago so there`s nothing new about it that`s for sure but the fact I posted early Feb & early March as opposed to no definitive end date , is that positive of negative ?
Also I see the 240m-400m warrants extended to the start of Feb & March line that LG and DI have told many warrant holders has been posted by AEKust this morning, do you think that`s a bad thing that its now in the public domain ?
To my mind when this is properly digested punters will be left
with no doubt the extensions do not mean TLD in mid to late January ie a few days trading days prior to the Feb 1st exercise date, it means anytime from kind of now to first week of January and a few days prior to a Lancet or equivalent publication noting that the Lancet publish weekly and have fast track for data release. The Lancet's next publication dates are 12th & 19th December...
So the result of yesterdays `rukus` is that :
a) We know the extensions are short dated and there`s no longer room for the bashers to start the ASCO 2030 b/s
b) We know they are aiming for 400m to be tied up which I think is
100m + more than last time.
Net net to my mind we are in a better place than we were Friday night and have removed a great deal of conjecture over wtf is going on with the December 15th exercise date.
Last but not least we can assume Marzan was probably not the first to be called re the warrants so they`ve been working on this for at least a month, so must be close to conclusion if not already sorted.
So you believed in the product 8 years ago on scant little evidence and now on the eve of data you're `seriously considering cashing in my chips and taking the handsome profit I've already made` ..because the management have missed time lines and not filed official docs .... err ie exactly what they've been doing for the last 8 years in fact..
So in my opinion you really should sell on the open today , turn the message board off and enjoy your handsome profits.
All the best and bibi ..
Ha. Thanks, should we trade anything > $5. before 18th Dec youre all invited !!
Last time I was at that particular restaurant I was on a table beside Donald Sutherland , and Johnny Depp was opposite ( yes that Johnny Depp )
Excuse the name dropping :)
..we are all pissing in the wind ...but to my mind as you all know I despise the management but if they've extended the warrants to give us a chance at a run which in turn gets Poignant the pps for the uplist application to NYSE then thats all good by me and it will give leverage to them as they final price is agreed with Merck.
TLD pre 15th Dec will make my birthday dinner at The Ivy all the sweeter ...
I am sure they were, I'm saying that your point about a CEO self -serving would not really stand up as long as she waived the sweetener that was offered to other holders .. and I would strongly believe she would know that
Well if 3% or so was offered again BUT not to the insiders I dont see a problem ...
If she gave herself more warrants ie a sweetner , then of course but she is far from stupid.
Look it really all boils down to do you think they are unblinded, and for my 9 weeks post DL they are 1000000%. friggin defo unblinded .
..And if you agree with that then there's no way they could extend warrants even with sweeteners and therefore defacto we must have met the primary endpoint at the very least.
Sorry you have to give me a bit more into re LP's warrants for me to see what your driving at ?
I guess you mean last time they were blinded ?
Im saying that offering incentives to extend the warrants post being unblinded would not be an issue as long as the terms did not indicate if the trial data that they were unblinded to were good or bad.
If the data were bad then they would indeed leave themselves open to future law suits but if they were good I cant imagine law suits flying can you ?
If the driver of the extensions was to indeed give the share price a chance following release of data then that comes under their primary responsibility which is of course ... altogether now 'create shareholder value !!'
If there were sweeteners in line with the previous incentives
I don’t see that as any problem whether they were unblinded or not
... and of course they were unblinded.
Changing the FDA endpoints cures all ills ...
Yes its certainly changed the general mood which as the evenings have become afternoons had understandably intensified the ill ease feeling with it all.
I have the 5 minute tests carried out by a nurse for all staff that want it every week, I guess the screams may be missed by some !
Soj , that`s rubbish its been knowledge to anyone with any kind of serious position since Marzan posted it weeks ago if not before ,
Zip317 why not try being proactive , pick the phone up dial Innes number and ask him have the warrants been extended,... its not difficult ..albeit old fashioned ...
I look forward to you reporting back ...
...the company 10000000% is UNBLINDED , Innes may not be but the execs are ..
...it is , I cant understand what the big deal is tbh ...
Tiny Sticks you could always pick the phone up to DI and simply ask him...
Yes I guess you could call it its inside information but not `inside` information as such ..
It would be pretty difficult to gauge the appetite to extend without speaking to the holders.
For the last time warrants have been extended ask Marz ..
Marzan will confirm to you I`m sure ... he's a warrant holder and was the first to post the extensions of Dec 15th's weeks ago in fact he was so early with that info I didnt believe him but I was wrong ..
Yes there`s low to no shares available to borrow...
On changing the FDA endpoints we will trade $3 ish in the very next session
On any even mildly positive news we will trade $2.00 ish this week
On no news we will trade up to 1.80 ish this week ..